The Epitranscriptome of Long Noncoding RNAs in Metabolic Diseases.

The Epitranscriptome of Long Noncoding RNAs in Metabolic Diseases.
Clin Chim Acta. 2021 Jan 07;:
Authors: Yin L, Zhu X, Novák P, Zhou L, Gao L, Yang M, Zhao G, Yin K
Abstract
Long noncoding RNAs (lncRNAs) have abundant content and extensive functions that regulate the expression of genes at multiple levels. Recently, transcriptome-wide analysis confirmed that RNA can undergo various chemical modifications in response to stimulation by the environment that further determine the action mechanisms of RNAs and expand the diversity of the transcriptome. Modifications that occur in lncRNAs can affect their expression and the regulation of downstream molecules by changing the secondary structure, splicing, degradation or molecular stability of lncRNAs. During the development of metabolic diseases, reversible RNA modifications show a complex transcriptional landscape. Although a wide quantity and variety of lncRNA modifications have been identified, the knowledge regarding their underlying actions in alcohol use disorders (AUDs), osteoporosis, obesity, and cardiovascular disease (CVD) is still in its infancy. Herein, we will focus on the epitranscriptomic modifications that occur on lncRNAs and the crosstalk between them that affect metabolic diseases.
PMID: 33422492 [PubMed - as supplied by publisher]

Source: International Journal of Clinical Chemistry - January 7, 2021 Category: Chemistry Authors: Yin L, Zhu X, Novák P, Zhou L, Gao L, Yang M, Zhao G, Yin K Tags: Clin Chim Acta Source Type: research